Evolution of the Average Target: Cardiol Therapeutics Inc.

Evolution of the Average Target - Cardiol Therapeutics Inc.

Evolution of the Target Price: Cardiol Therapeutics Inc.

Evolution of the Target Price - Cardiol Therapeutics Inc.

Changes in Analyst Recommendations: Cardiol Therapeutics Inc.

2904.YxiXdCSXODokgWu2JDJW3lIT-06tBaayb2VSL8Ynnig.C12lTRTVD39RxySbfmBh7WRbyQzLd8iEKA4_bpEWqk48YsY_cPlUZWfUJg~25d8090be04355bec77362b59faada9f

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +376.19%
+38.3%
+15.44%
+7.53%
+12.65%
+17.64%
+59.48%
+30.16%
+17.66%
+60.27%
Average +63.53%
Weighted average by Cap. +26.58%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.390CAD
Average target price
7.000CAD
Spread / Average Target
+403.60%
High Price Target
7.000CAD
Spread / Highest target
+403.60%
Low Price Target
7.000CAD
Spread / Lowest Target
+403.60%

Analyst Consensus Detail

Analyst consensus - Cardiol Therapeutics Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Cardiol Therapeutics Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Cardiol Therapeutics Inc.
  1. Stock Market
  2. Stocks
  3. CRDL Stock
  4. Consensus Cardiol Therapeutics Inc.